Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr Read more
Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs Read more
Navrogen Enters into CRADA with The U.S. National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate Read more
Mauna Kea Technologies and Tasly Pharmaceutical Announce the Incorporation of Joint Venture in China Read more
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company Read more
Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders Read more
AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN LIPOPROTEIN(A) LEVELS Read more